Panion & BF Biotech Inc.(TW:1760)
NT$47.70-1.65 (-3.34%)
TW:1760
Panion & BF Biotech Inc. financials statements
NT$47.70
At close:-1.65 (-3.34%)
Panion & BF Biotech Inc. (1760) Financial Statements
Panion & BF Biotech Inc. Financial Overview
Panion & BF Biotech Inc.'s market cap is currently NT$4.23B. The company's EPS TTM is NT$2.51; its P/E ratio is 24.71; and it has a dividend yield of 4.19%. Panion & BF Biotech Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 2.06B | NT$ 2.03B | NT$ 1.88B | NT$ 2.40B | NT$ 1.90B |
| Gross Profit | NT$ 1.12B | NT$ 1.07B | NT$ 974.40M | NT$ 1.32B | NT$ 912.14M |
| Operating Income | NT$ 307.85M | NT$ 205.67M | NT$ 156.83M | NT$ 341.07M | NT$ 199.42M |
| EBITDA | NT$ 446.27M | NT$ 405.32M | NT$ 327.22M | NT$ 504.62M | NT$ 343.05M |
| Net Income | NT$ 190.17M | NT$ 124.52M | NT$ 77.22M | NT$ 182.34M | NT$ 104.40M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 460.32M | NT$ 558.37M | NT$ 534.63M | NT$ 464.26M | NT$ 348.89M |
| Total Assets | NT$ 3.23B | NT$ 3.21B | NT$ 3.24B | NT$ 3.09B | NT$ 2.95B |
| Total Debt | NT$ 647.70M | NT$ 704.86M | NT$ 727.83M | NT$ 482.33M | NT$ 502.56M |
| Net Debt | NT$ 187.39M | NT$ 146.49M | NT$ 193.21M | NT$ 18.07M | NT$ 223.46M |
| Total Liabilities | NT$ 1.27B | NT$ 1.29B | NT$ 1.32B | NT$ 1.09B | NT$ 1.02B |
| Stockholders' Equity | NT$ 1.95B | NT$ 1.92B | NT$ 1.91B | NT$ 2.01B | NT$ 1.93B |
| Cash Flow | |||||
| Free Cash Flow | NT$ 150.37M | NT$ 165.49M | NT$ -3.81M | NT$ 291.23M | NT$ 231.22M |
| Operating Cash Flow | NT$ 298.71M | NT$ 351.19M | NT$ 177.42M | NT$ 489.87M | NT$ 401.23M |
| Investing Cash Flow | NT$ -133.37M | NT$ -158.77M | NT$ -155.27M | NT$ -144.47M | NT$ -215.05M |
| Financing Cash Flow | NT$ -262.85M | NT$ -170.51M | NT$ 48.67M | NT$ -167.39M | NT$ -217.76M |
Currency in TWD
